Especially, WT1bi_alt or WT1mono_alt/FLT3-ITD co-mutations were observed in most relapses, whereas patients with these features at AML diagnosis were more likely to be refractory to induction chemotherapy. The gene discussed is FLT3; the disease is acute myeloid leukemia.